England's Cosmetic Licensing Scheme: What Regulation Is Actually Coming

For a long time the central fact about non-surgical aesthetics in England was an absence: there was no comprehensive licensing regime. In much of the sector, the bar to performing injectable procedures was strikingly low — far lower than the public generally assumed. The same substance that requires a prescriber to authorise it could be injected, in practice, by someone with minimal formal training, in premises subject to little oversight. That gap is the backdrop to almost every harm story in this field.

That is now changing, although more slowly and more incrementally than the headlines sometimes suggest. England is moving toward a licensing scheme for non-surgical cosmetic procedures, and it is worth understanding what is actually proposed, what is already settled, and what remains genuinely uncertain — because the distance between "regulation is coming" and "regulation is here" is where a lot of the current confusion lives.

Where this comes from

The legal foundation was laid by the Health and Care Act 2022, which gave the government the power to introduce a licensing scheme for non-surgical cosmetic procedures in England. Powers in legislation, however, are not the same as a running scheme. The detail — which procedures, what standards, who enforces it, what training is required — has to be filled in through consultation and secondary legislation, and that process has been unfolding across 2025 and into 2026.

The direction is a risk-based one. The stated intention is to restrict the highest-risk procedures first, with further public consultation continuing into 2026 to settle the detail. This matters because it means the scheme is not arriving as a single switch flipped on one day; it is arriving in stages, with the riskiest interventions prioritised.

What the scheme is expected to require

The broad shape is a licensing system, expected to be administered by local authorities, under which both practitioners and premises must meet defined standards to operate legally. For practitioners, that points toward demonstrating appropriate training, holding proper insurance, and meeting hygiene and safety standards. For premises, it points toward standards for the environment in which procedures are carried out.

A few specifics have firmer outlines. Procedures involving botulinum toxin and dermal fillers are squarely within the scope of the emerging scheme — these are the core of the non-surgical market and the source of much of its harm. There is a strong emphasis on training: practitioners performing toxins and fillers are increasingly expected to hold high-level qualifications, with a Level 7 qualification (broadly master's-level) cited as the benchmark for injectable practice. And one rule is already firm and in force: under the Botulinum Toxin and Cosmetic Fillers (Children) Act 2021, it is a criminal offence to provide botulinum toxin or filler for cosmetic purposes to anyone under 18 in England — an age restriction that came into force in October 2021 and predates the full licensing scheme.

Alongside the licensing scheme sits a parallel tightening on prescribing. Botulinum toxin is a prescription-only medicine, and there has been a concerted move to clamp down on "remote prescribing" — the practice of a prescriber authorising toxin for someone they have not properly evaluated in person. The expectation is moving firmly toward genuine, face-to-face assessment by the prescriber. This is its own important strand and is covered in more detail elsewhere in this section.

What is still uncertain

It would be misleading to present the scheme as fully settled. Several things remain in motion. The precise list of which procedures fall into which risk tier — and therefore what is restricted first — is still being worked through. The exact standards practitioners and premises must meet, and the qualifications that will count, are subject to ongoing consultation. Enforcement capacity is an open question: a scheme administered by local authorities is only as effective as the resources those authorities have to police it, and the sector is large. And there is the perennial issue of the unregulated fringe — operators who will continue outside the rules regardless, which is why criminal enforcement against illegal product supply runs alongside the licensing effort rather than instead of it.

In other words: the framework is coming, its broad shape is visible, but anyone claiming precise certainty about the final detail in mid-2026 is getting ahead of the process.

Why it matters beyond the industry

The significance of this is not bureaucratic. The non-surgical aesthetics market grew explosively in an environment where consumer protection depended largely on luck and the individual conscientiousness of operators. The harms documented across this section — vascular complications managed by people unequipped to manage them, counterfeit product reaching arms, high-risk procedures performed in unsuitable settings — are in large part the predictable consequences of that gap. A licensing scheme, properly resourced and enforced, is an attempt to make safety a condition of operating rather than a matter of chance.

For anyone considering a procedure now, in the transitional period, the practical reading is this: the protections the scheme promises are not yet fully in place, so the burden still falls heavily on individual judgement — on choosing a properly trained practitioner, a genuine prescriber, a licensed product, and a setting equipped to manage complications. The regulation is arriving, but until it has fully arrived, the safeguards it will eventually provide are still substantially the individual's to seek out.

Practical takeaways

• England is introducing a licensing scheme for non-surgical cosmetic procedures, built on powers in the Health and Care Act 2022, rolling out in stages through 2025–2026.
• The approach is risk-based, restricting the highest-risk procedures first, with further consultation continuing into 2026.
• The scheme is expected to require practitioners and premises to meet standards on training, insurance, hygiene and safety, administered by local authorities; botulinum toxin and fillers are central to its scope.
• It is already illegal to give botulinum toxin or filler for cosmetic purposes to under-18s in England (Botulinum Toxin and Cosmetic Fillers (Children) Act 2021), and remote prescribing of toxin is already prohibited by professional-regulator guidance.
• Much detail — exact procedures, standards, and enforcement — remains uncertain; the framework is coming but not yet fully in force.

What this doesn't mean

This is not a claim that the scheme is finalised, nor that regulation alone will eliminate harm. It is a description of a framework in progress: real, significant, and incomplete. During the transition, the safeguards it promises cannot yet be assumed to be in place everywhere.

When to seek medical advice

This is an editorial overview of regulation, not clinical guidance. If you are considering a non-surgical cosmetic procedure, a qualified clinician or pharmacist can help you understand the specific risks for your situation, and you should always seek prompt medical attention for any complication after a procedure — telling whoever assesses you exactly what was done.

A closing thought

"Regulation is coming" has become a comfortable phrase in UK aesthetics, repeated so often that it can sound like a thing already achieved. It is more accurate, and more useful, to say that regulation is being built — in stages, with real intent, and with significant detail still unsettled. The gap between the announcement and the working scheme is exactly the period the public is living through now, and it is a period in which the old burden on individual judgement has not yet lifted.

Further reading and sources

• House of Commons Library — the regulation of non-surgical cosmetic procedures in England
• Understanding the new regulations for non-surgical cosmetic procedures — Browne Jacobson
• Botulinum Toxin and Cosmetic Fillers (Children) Act 2021 — legislation.gov.uk
• MHRA crackdown on illegal 'Botox' — GOV.UK

Brand names are mentioned for identification only. The author has no commercial relationship with any manufacturer, and nothing here is an advertisement for, or recommendation to obtain, any medicine.